文献速递肝胆胰外科围术期管理与 ERAS

肝内胆管癌肝切除术前风险评分与长期预后预测

Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.
PubMed 文献 · J Am Coll Surg · 2017-12-21

该研究基于16个肝胆中心1990–2015年538例肝内胆管癌肝切除患者,利用术前肿瘤大小、CA19-9、白蛋白及中性粒细胞/淋巴细胞比值构建加权复合预后评分,在训练集与验证集AUC分别为0.696与0.691,优于AJCC第8版T分期与累积分期,可用于术前医患沟通与预期管理。

要点

  • 术前肿瘤大小、CA19-9、白蛋白及NLR与ICC肝切除长期生存独立相关。
  • 加权复合评分预测效能优于AJCC第8版T分期与累积分期。
  • 风险评分≥25预测术后1年内死亡阳性预测值为59.8%。

核心结论

  • 基于术前临床参数的加权复合评分可预测ICC肝切除术后长期生存。

研究设计与样本

  • 多中心回顾性队列研究,纳入16个肝胆中心1990–2015年538例ICC肝切除患者,分训练集与验证集构建并验证预后模型。

主要发现

  • 中位总生存39.0个月,5年总生存率39.0%。
  • 多变量分析显示肿瘤大小(HR 1.12,95%CI 1.06–1.18)、CA19-9自然对数(HR 1.33,95%CI 1.22–1.45)、白蛋白(HR 0.76,95%CI 0.55–0.99)及NLR(HR 1.05,95%CI 1.02–1.09)与长期生存相关。
  • 模型在测试集AUC为0.696、验证集AUC为0.691,优于T分期(AUC 0.532)与AJCC第8版累积分期(AUC 0.559)。
  • 风险评分≥25预测术后1年内死亡阳性预测值为59.8%,高于AJCC第8版T4的35.3%与IIIB期的31.8%。

关键数值与推荐

  • 预后评分公式:9 + (1.12×肿瘤大小) + (2.81×CA19-9自然对数) + (0.50×NLR) + (-2.79×白蛋白)。
  • 风险评分≥25提示术后1年内死亡风险较高,阳性预测值59.8%。

临床怎么用

  • 术前可采用该评分评估ICC患者肝切除长期预后,辅助医患沟通与预期管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Accurate prediction of prognosis for patients with intrahepatic cholangiocarcinoma (ICC) remains a challenge. We sought to define a preoperative risk tool to predict long-term survival after resection of ICC. STUDY DESIGN: Patients who underwent hepatectomy for ICC at 1 of 16 major hepatobiliary centers between 1990 and 2015 were identified. Clinicopathologic data were analyzed and a prognostic model was developed based on the regression β-coefficients on data in training set. The model was subsequently assessed using a validation set. RESULTS: Among 538 patients, most patients had a solitary tumor (median tumor number 1; interquartile range 1 to 2) and median tumor size was 5.7 cm (interquartile range 4.0 to 8.0 cm). Median and 5-year overall survival was 39.0 months and 39.0%, respectively. On multivariable analyses, preoperative factors associated with long-term survival included tumor size (hazard ratio [HR] 1.12; 95% CI 1.06 to 1.18), natural logarithm carbohydrate antigen 19-9 level (HR 1.33; 95% CI 1.22 to 1.45), albumin level (HR 0.76; 95% CI 0.55 to 0.99), and neutrophil to lymphocyte ratio (HR 1.05; 95% CI 1.02 to 1.09). A weighted composite prognostic score was constructed based on these factors: [9 + (1.12 × tumor size) + (2.81 × natural logarithm carbohydrate antigen 19-9) + (0.50 × neutrophil to lymphocyte ratio) + (-2.79 × albumin)]. The model demonstrated good performance in the testing (area under the curve 0.696) and validation (0.691) datasets. The model performed better than both the T categories (area under the curve 0.532) and the cumulative stage classifications in the American Joint Committee on Cancer staging manual, 8th edition (area under the curve 0.559). When assessing risk of death within 1 year of operation, a risk score ≥25 had a positive predictive value of 59.8% compared with a positive predictive value of 35.3% for American Joint Committee on Cancer staging manual, 8th edition T4 disease and 31.8% for stage IIIB disease. CONCLUSIONS: Postsurgical long-term outcomes could be predicted using a composite weighted scoring system based on preoperative clinical parameters. The preoperative risk model can be used to inform patient to provider conversations and expectations before operation.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Sasaki K, Margonis GA, Andreatos N, et al. Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma. J Am Coll Surg. 2017. PMID: 29274841. doi:10.1016/j.jamcollsurg.2017.12.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。